<p>Surface modification is crucial for improving bone-implant integration, but current coating technologies lack simplicity, efficiency, and multifunctionality needed for clinical use. Metal-phenolic networks (MPNs) are emerging as a promising biomaterial interface that addresses osseointegration challenges through precise physicochemical design. Our study introduces a gallic acid-arginine@zinc (GA-Arg@Zn) MPN coating that promotes favorable host responses in the following ways: (1) Immunomodulation: Shifting macrophages towards CD206<sup>+</sup> anti-inflammatory phenotypes while reducing TNF-α, IL-1β, and IL-6 secretion to create an immunoregulatory environment that minimizes fibrous encapsulation. (2) Osteopromotion: Enhancing bone marrow stromal cell (BMSC) osteogenic differentiation by increasing ALP activity and OCN expression through modulation of the ionic microenvironment. (3) Biointerface Engineering: Establishing an immunologically favorable osteogenic microenvironment that boosts BMSC recruitment and mineralization capacity through paracrine signals from macrophages. This self-reinforcing “immuno-osseous” regenerative axis integrates material-induced immunomodulation with stem cell activation, representing a significant advancement in orthopedic interface engineering. The coating’s rapid aqueous deposition and inherent antibacterial properties further highlight its clinical promise.</p> Graphical abstract <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Multifunctional metal-phenolic network coatings drive immunocompetent osseointegration via marrow microenvironment remodeling

  • Yu-Wei Ge,
  • Nai-sheng Zhai,
  • Chen-jun Liu,
  • Xin Wang,
  • Guang Yang,
  • Liang Yang,
  • Lin-yuan Shu,
  • Hui Sun

摘要

Surface modification is crucial for improving bone-implant integration, but current coating technologies lack simplicity, efficiency, and multifunctionality needed for clinical use. Metal-phenolic networks (MPNs) are emerging as a promising biomaterial interface that addresses osseointegration challenges through precise physicochemical design. Our study introduces a gallic acid-arginine@zinc (GA-Arg@Zn) MPN coating that promotes favorable host responses in the following ways: (1) Immunomodulation: Shifting macrophages towards CD206+ anti-inflammatory phenotypes while reducing TNF-α, IL-1β, and IL-6 secretion to create an immunoregulatory environment that minimizes fibrous encapsulation. (2) Osteopromotion: Enhancing bone marrow stromal cell (BMSC) osteogenic differentiation by increasing ALP activity and OCN expression through modulation of the ionic microenvironment. (3) Biointerface Engineering: Establishing an immunologically favorable osteogenic microenvironment that boosts BMSC recruitment and mineralization capacity through paracrine signals from macrophages. This self-reinforcing “immuno-osseous” regenerative axis integrates material-induced immunomodulation with stem cell activation, representing a significant advancement in orthopedic interface engineering. The coating’s rapid aqueous deposition and inherent antibacterial properties further highlight its clinical promise.

Graphical abstract